Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Patients with acne vulgaris (AV) appeared to be a chronic inflammation with a wide range in
teenagers and adult. The protocol design is as follows.
The subjects enrolled through inclusion and exclusion criteria will undergo the blood and
urine biochemical tests for baseline record. The photos from the subjects will be recorded
per day, and the blood and urine biochemical tests will be recorded per week.
Objectives: primary: to test the toxicity of topical minoxidil in treatment of acne vulgaris;
second: to evaluate the response and disease control rate in this pilot study.
Measurement: Time to resolution of individual acne lesions (14 days) Monitor of treatment
efficacy: number of inflammatory acne lesions counting, time to resolution of individual acne
lesion, and degree of acne severity measurement.